Latest News about AZN

Recent news which mentions AZN

...

26 27 28 29 30 31 32 33 Next >

AstraZeneca (AZN) Announces Approval of ENHERTU (HER2-low Metastatic Breast Cancer) in the United States

August 08, 2022

Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment

August 08, 2022

Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders

August 08, 2022

AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting

August 08, 2022

3 Unstoppable Stocks That Don't Care About the Bear Market

August 07, 2022

Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal

August 05, 2022

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

August 04, 2022

Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs

August 04, 2022

AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy

August 04, 2022

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

August 04, 2022

Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus

August 02, 2022

Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody

August 01, 2022

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

August 01, 2022

AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer

August 01, 2022

Do These 3 New Moneymakers for AstraZeneca Make It a Buy?

July 31, 2022

3 Stocks We Think Could Beat the Market in the Second Half of 2022

July 30, 2022

AstraZeneca Drops Moderna-Partnered, Phase 2 Heart Disease Drug Candidate

July 29, 2022

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update

July 29, 2022

Recap: AstraZeneca Q2 Earnings

July 29, 2022

Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29

July 29, 2022

AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance

July 29, 2022

Earnings Scheduled For July 29, 2022

July 29, 2022

$100 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today

July 28, 2022

FDA Accepts AstraZeneca's Submission For Low Breast Cancer Candidate Under Priority Review

July 25, 2022

Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact

July 25, 2022

U.S. Stock Futures Higher; Crude Oil Rises 1%

July 25, 2022

Europe's CHMP Recommends Approving AstraZeneca's Asthma, Neuromuscular Disorder Treatments

July 25, 2022

Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace

July 24, 2022

2 Unstoppable Stocks Set to Keep Beating the Market in 2022

July 23, 2022

2 Pharma Giants With Momentum That Could Carry Through 2030

July 22, 2022

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.